MondayAug 30, 2010 8:55 am

IntelGenx Corp. (IGXT.OB) and RedHill Biopharma Ltd. Announce Agreement for Anti-Migraine Film Product

IntelGenx Corp. has focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems to separate themselves from the competition in the medical sector. Today, IntelGenx took a major step forward with the announcement that they have entered a definitive agreement with RedHill Biopharma for an Anti-Migraine film product. The product is intended for the rapid relief of migraines and will be the first oral thin film product based upon IntelGenx's proprietary VersaFilm technology. The terms of this co-development and commercialization agreement will have Red Hill obtaining certain exclusive rights to market and sell the…

Continue Reading

MondayAug 30, 2010 8:45 am

Uranium Energy Corp. (UEC) Announces Completion of First Phase of Wellfield Development at Palangana in South Texas

Uranium Energy Corp. was pleased to announce this morning that it has completed the first of three phases of wellfield development at Production Area One ("PAA-1") at the Palangana ISR uranium project located in South Texas. According to the press release, Uranium Energy completed 40 injection and production wells thus far, marking the end of Phase One in the development of PAA-1. The wells are to be brought on-stream in three approximately equivalent phases as part of the build-up to initial sustainable levels of production. Construction of Palangana's ion-exchange satellite facility is also underway with pumps and tanks to be…

Continue Reading

MondayAug 30, 2010 8:11 am

Forbes Medi-Tech (FMTI.OB) Closes Asset Sale and Updates Shareholders on Schedule of Liquidation

Forbes Medi-Tech, Inc. issued a press release after the closing bell on Friday to announce the closing of an asset sale in which the majority of its assets have been sold to Pharmachem Laboratories, Inc. In negotiation since July, this sale was previously announced as accepted on August 20, 2010 in which terms were reached at US$4.0 million. This dollar amount is significantly higher than the amount offered by MHT, LLC as announced in initial negotiations for an asset sale as announced in July. Pharmachem Laboratories is a U.S.-based manufacturer and supplier of ingredients, including nutritionals, food and beverages, flavors…

Continue Reading

FridayAug 27, 2010 4:05 pm

Cleveland BioLabs (CBLI) Poised to Capitalize Massively on Multiple Government Contracts for Radiation Countermeasures

Cleveland BioLabs, www.cbiolabs.com, is well-positioned as both a bio-defense and medical company, with proficiencies in radiation countermeasures, as well as preclinical cancer, stem cell and acute organ failure technologies. President and CEO of CBLI, Michael Fonstein, detailed excitement over CBLB502, the Company’s radiation countermeasure being favorably positioned to receive the final contract award by the DOD (pursuant to a Q1 FY10 Request For Proposal response). In an exclusive interview with BioMedReports, Fonstein revealed that the CBLB502 defense program is based on CBLI’s unique pharmacological approach of achieving radioprotectant (preventative) and radiation damage mitigation parameters via Protectans, molecules which shield the…

Continue Reading

FridayAug 27, 2010 4:03 pm

Bakers Footwear Group, Inc. (BKRS.OB) Seals $5M Debt and Equity Financing Deal

Bakers Footwear, www.bakersshoes.com, has managed to develop an intricate market relationship between retail space and customers by offering a robust array of fashion-forward footwear and accessories for style-driven young women ages 16-35 at its national network of some 240 stores. The Company announced today that it has obtained a $5M debt and equity investment from Steven Madden, Ltd., receiving $4.6M in net proceeds which will be directed towards working capital. Subordinate to outstanding debt, the $5M note carries 11% interest (principal payments due 2017-2020), and a reported 1,844,860 shares will be issued to Steven Madden in addition, as consideration for…

Continue Reading

FridayAug 27, 2010 12:43 pm

Synergy Resources Corp. (SYRG) Completes Oil and Gas Drilling Program

Synergy Resources Corp. reported that the company has completed the final well in its oil and gas exploration and development program. The drilling program had a 100% success rate. Synergy Resources Corporation said that twenty-two of the wells have been completed, and the other fourteen wells are in the process of being completed by the company and should be producing by the middle of September 2010. The oil and gas exploration and development program conducted by Synergy Resources Corporation was spread across several different basins and formation, with a concentration in the Niobrara, Codell and J-Sand. Synergy Resources Corporation reported…

Continue Reading

FridayAug 27, 2010 12:41 pm

Morgan Creek Energy Corp. (MCKE) Signs Deal to Purchase Mississippi Oil and Gas Properties

Morgan Creek Energy Corp. announced that the company has signed a contract to acquire 21,000 net acres of oil and gas leases in the southern United States. Morgan Creek Energy Corp. reported that the oil and gas leases are located in Mississippi in Lamar, Forrest and Jones Counties. Morgan Creek Energy Corp. said that the company would be developing multiple formations on the newly acquired acreage in Mississippi including the Eutaw, Haynesville and Tuscaloosa zones. Morgan Creek Energy Corp. is purchasing the oil and gas leases from the Westrock Land Corp., which has warranted that the company has clear title…

Continue Reading

FridayAug 27, 2010 12:40 pm

American Jianye Greentech Holdings (AJGH.OB) Announces Record Income

American Jianye Greentech Holdings, a leading producer and distributor of alcohol-based automobile and civil use fuels, located in China, today announced a 138% increase in sequential sales, along with a record net income of $2.1 million, or $0.07 per share, for the second quarter ended June 30, 2010. • Revenue - The company reported revenue of $22.9 million for the second quarter, versus $9.6 million for the first quarter 2010, and $0.0 for the second quarter of 2009. • Gross Profit – The company reported gross profit of $2.9 million for the second quarter, versus $1.5 million for the first…

Continue Reading

FridayAug 27, 2010 11:27 am

Cord Blood America, Inc. (CBAI.OB) Announces $50k Guarantee

Cord Blood America is a company that continues to separate themselves from the competition. Located in Las Vegas, Nevada, Cord Blood is the parent company of the popular CorCell which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Cord Blood has the mission of evolving into the most respected stem cell preservation company in the industry. Today, Cord Blood took a major step towards achieving that goal. Cord Blood America made news with the announcement of a $50,000 Quality Service Guarantee. The Guarantee will pay the owner of the umbilical cord blood stem cells $50,000…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered